-+ 0.00%
-+ 0.00%
-+ 0.00%

Amgen shares fell 5.4% in the premarket; late-stage clinical trials of rival Novartis cholesterol drugs failed.

Zhitongcaijing·09/08/2026 08:33:13
Listen to the news
Amgen shares fell 5.4% in the premarket; late-stage clinical trials of rival Novartis cholesterol drugs failed.